Tags:BioTechBodyInformationITLearnMedtechPersonalPlatformStorageTechnology
Our gene therapies are designed to halt or reverse progression of lysosomal disorders with a single infusion. Learn about us, our focus and technology, sign up for updates, and read articles to expand your gene therapy knowledge.
Location: United States, Massachusetts, Boston
Member count: 51-200
Total raised: $85M
Founded date: 2015
Founders name: Chris Mason
Founders Related Locations: Cambridge, MA, USA

Investors 3

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
01.02.2018Series B$60M-aislingcap...
02.08.2016Series A$25M-fiercebiot...

Mentions in press and media 15

DateTitleDescriptionCategoryAuthorSource
05.02.2018Capitalizi...Announced Thursday, the raise ...--medcitynew...
02.02.2018Term Sheet...IPO DELAYS Good morning, Term...--fortune.co...
01.02.2018Avrobio Ra...Avrobio, a Cambridge, Mass.-ba...USA-finsmes.co...
01.02.2018AVROBIO, I...CAMBRIDGE, Mass.–(BUSINESS WIR...--aislingcap...
01.02.2018AVROBIO Re... CAMBRIDGE, MA, AVROBIO annou...--vcnewsdail...
01.02.2018AVROBIO, I...Company to initiate Phase 2 tr...--svhealthin...
01.02.2018AVROBIO Ra...AVROBIO, Inc., a clinical-stag...--citybizlis...
01.02.2018Avrobio pu...Avrobio has raised $60 million...Biotech-fiercebiot...
02.08.2016Avrobio Ra...Avrobio, Inc., a Cambridge, MA...USA-finsmes.co...
02.08.2016AVROBIO Ra...CAMBRIDGE, Mass.--(BUSINESS WI...--citybizlis...
Show more